MAC-话题@MedSci

#MAC#

655篇内容 | 2761人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1996187, encodeId=807d199618e37, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Biol Macromol：DCTPP1过表达诱导的自噬能够促进肿瘤恶化和预测前列腺癌不良临床治疗结果, objectType=article, longId=141807, objectId=43ea14180eca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ea14180eca, replyNumber=0, likeNumber=49, createdTime=2019-02-20, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ea14180eca, moduleTitle=Int J Biol Macromol：DCTPP1过表达诱导的自噬能够促进肿瘤恶化和预测前列腺癌不良临床治疗结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43ea14180eca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996294, encodeId=8c5a1996294a3, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Biol Macromol:柠檬酸交联的NaCMC-HPMC水凝胶膜可用作伤口敷料, objectType=article, longId=166003, objectId=49d9166003dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49d9166003dd, replyNumber=0, likeNumber=60, createdTime=2020-01-20, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49d9166003dd, moduleTitle=Int J Biol Macromol:柠檬酸交联的NaCMC-HPMC水凝胶膜可用作伤口敷料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49d9166003dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996265, encodeId=d5c81996265fa, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, objectType=article, longId=159002, objectId=515c159002e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515c159002e4, replyNumber=0, likeNumber=57, createdTime=2019-03-14, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515c159002e4, moduleTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=515c159002e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996231, encodeId=8fa51996231b4, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Trends Pharmacol Sci：一石二鸟!长寿药竟可治疗阿尔茨海默病！, objectType=article, longId=153969, objectId=3d8215396978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d8215396978, replyNumber=0, likeNumber=55, createdTime=2019-03-06, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d8215396978, moduleTitle=Trends Pharmacol Sci：一石二鸟!长寿药竟可治疗阿尔茨海默病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d8215396978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996184, encodeId=0e3b199618404, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Macromol Biosci：明胶电纺膜的制备、改性后和抗菌应用, objectType=article, longId=141679, objectId=510a1416e9e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=510a1416e9e5, replyNumber=0, likeNumber=45, createdTime=2018-11-21, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=510a1416e9e5, moduleTitle=Macromol Biosci：明胶电纺膜的制备、改性后和抗菌应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=510a1416e9e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996263, encodeId=a6d419962633e, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Int J Biol Macromol：台科大发明自组装纳米粒子，或可实现胰岛素口服给药, objectType=article, longId=158538, objectId=d09715853867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d09715853867, replyNumber=0, likeNumber=88, createdTime=2019-12-13, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d09715853867, moduleTitle=Int J Biol Macromol：台科大发明自组装纳米粒子，或可实现胰岛素口服给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d09715853867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996176, encodeId=0d2519961e6a1, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther：首次急性冠脉综合征后二级预防的推荐药物, objectType=article, longId=141354, objectId=c16614135475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16614135475, replyNumber=0, likeNumber=54, createdTime=2019-02-27, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16614135475, moduleTitle=Clin Pharmacol Ther：首次急性冠脉综合征后二级预防的推荐药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16614135475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996285, encodeId=f9aa199628561, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, objectType=article, longId=164907, objectId=fe4216490eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4216490eae, replyNumber=0, likeNumber=62, createdTime=2019-04-25, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4216490eae, moduleTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4216490eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996232, encodeId=cffb19962320f, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=CLIN CANCER RES：Abemaciclib联合其他药物治疗非小细胞肺癌患者, objectType=article, longId=154098, objectId=33f915409826, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33f915409826, replyNumber=0, likeNumber=67, createdTime=2019-06-19, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33f915409826, moduleTitle=CLIN CANCER RES：Abemaciclib联合其他药物治疗非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33f915409826)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996252, encodeId=476419962525d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacotherapy：急症患者万古霉素联合哌拉西林-他唑巴坦急性肾损伤风险增加6.8倍, objectType=article, longId=156870, objectId=54441568e050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54441568e050, replyNumber=0, likeNumber=70, createdTime=2019-05-26, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54441568e050, moduleTitle=Pharmacotherapy：急症患者万古霉素联合哌拉西林-他唑巴坦急性肾损伤风险增加6.8倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54441568e050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996188, encodeId=064819961885f, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, objectType=article, longId=141968, objectId=8ab4141968fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab4141968fd, replyNumber=0, likeNumber=111, createdTime=2019-03-18, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab4141968fd, moduleTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab4141968fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996185, encodeId=5a09199618500, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Merrimack在中期研究失败后停止开发实验性胰腺癌治疗药物, objectType=article, longId=141737, objectId=6982141e37fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6982141e37fd, replyNumber=0, likeNumber=59, createdTime=2018-10-18, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6982141e37fd, moduleTitle=Merrimack在中期研究失败后停止开发实验性胰腺癌治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6982141e37fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996280, encodeId=98d1199628036, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Brit J Clin Pharmacol:他汀增加糖尿病风险获新证，胖人和HbA1c高者应警惕, objectType=article, longId=163317, objectId=816216331eff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=816216331eff, replyNumber=0, likeNumber=66, createdTime=2020-03-09, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=816216331eff, moduleTitle=Brit J Clin Pharmacol:他汀增加糖尿病风险获新证，胖人和HbA1c高者应警惕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=816216331eff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996201, encodeId=63f519962019a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur J Pharmacol：研究揭示杨梅素对人牙周膜干细胞成骨能力的影响及作用机制, objectType=article, longId=144888, objectId=7ec614488888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ec614488888, replyNumber=0, likeNumber=60, createdTime=2018-10-30, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ec614488888, moduleTitle=Eur J Pharmacol：研究揭示杨梅素对人牙周膜干细胞成骨能力的影响及作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ec614488888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996159, encodeId=11c8199615984, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Macromol Biosci：GO改性聚醚醚酮具有优良的抗菌成骨特性，或可作为骨组织工程的生物材料使用, objectType=article, longId=137251, objectId=b2e513e25135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2e513e25135, replyNumber=0, likeNumber=73, createdTime=2019-01-09, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2e513e25135, moduleTitle=Macromol Biosci：GO改性聚醚醚酮具有优良的抗菌成骨特性，或可作为骨组织工程的生物材料使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2e513e25135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996259, encodeId=02a519962595e, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？, objectType=article, longId=157468, objectId=098a15e468e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098a15e468e6, replyNumber=0, likeNumber=57, createdTime=2019-10-11, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098a15e468e6, moduleTitle=Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098a15e468e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996165, encodeId=31cd19961650c, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Ann Pharmacother：治疗肠梗阻、ACPO或难治性便秘新斯的明给药方式有讲究, objectType=article, longId=138503, objectId=a01113850386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a01113850386, replyNumber=0, likeNumber=69, createdTime=2019-03-20, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a01113850386, moduleTitle=Ann Pharmacother：治疗肠梗阻、ACPO或难治性便秘新斯的明给药方式有讲究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a01113850386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996248, encodeId=7f6f199624894, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, objectType=article, longId=156509, objectId=fcba1565093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcba1565093c, replyNumber=0, likeNumber=48, createdTime=2019-01-10, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcba1565093c, moduleTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcba1565093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996271, encodeId=ecae19962e140, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：二甲双胍通过GSK3β抑制促进人骨髓间充质干细胞向成骨细胞的分化, objectType=article, longId=159625, objectId=3872159625d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3872159625d1, replyNumber=0, likeNumber=55, createdTime=2020-01-04, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3872159625d1, moduleTitle=Eur Rev Med Pharmacol Sci：二甲双胍通过GSK3β抑制促进人骨髓间充质干细胞向成骨细胞的分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3872159625d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996236, encodeId=753f199623663, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？, objectType=article, longId=154369, objectId=4bff154369ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bff154369ef, replyNumber=0, likeNumber=70, createdTime=2019-04-22, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bff154369ef, moduleTitle=Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bff154369ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MAC

2020-05-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Biol Macromol：DCTPP1过表达诱导的自噬能够促进肿瘤恶化和预测前列腺癌不良临床治疗结果

2019-02-20

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Biol Macromol:柠檬酸交联的NaCMC-HPMC水凝胶膜可用作伤口敷料

2020-01-20

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症

2019-03-14

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Trends Pharmacol Sci：一石二鸟!长寿药竟可治疗阿尔茨海默病！

2019-03-06

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Macromol Biosci：明胶电纺膜的制备、改性后和抗菌应用

2018-11-21

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Int J Biol Macromol：台科大发明自组装纳米粒子，或可实现胰岛素口服给药

2019-12-13

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther：首次急性冠脉综合征后二级预防的推荐药物

2019-02-27

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可

2019-04-25

yb6560 (审核中...)

前往app查看评论内容

#MAC#

CLIN CANCER RES：Abemaciclib联合其他药物治疗非小细胞肺癌患者

2019-06-19

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacotherapy：急症患者万古霉素联合哌拉西林-他唑巴坦急性肾损伤风险增加6.8倍

2019-05-26

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？

2019-03-18

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Merrimack在中期研究失败后停止开发实验性胰腺癌治疗药物

2018-10-18

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Brit J Clin Pharmacol:他汀增加糖尿病风险获新证，胖人和HbA1c高者应警惕

2020-03-09

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur J Pharmacol：研究揭示杨梅素对人牙周膜干细胞成骨能力的影响及作用机制

2018-10-30

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Macromol Biosci：GO改性聚醚醚酮具有优良的抗菌成骨特性，或可作为骨组织工程的生物材料使用

2019-01-09

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Ann Pharmacother：产碳青霉烯酶肺炎克雷伯菌感染患者：双碳青霉烯联合疗法是否安全有效？

2019-10-11

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Ann Pharmacother：治疗肠梗阻、ACPO或难治性便秘新斯的明给药方式有讲究

2019-03-20

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？

2019-01-10

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：二甲双胍通过GSK3β抑制促进人骨髓间充质干细胞向成骨细胞的分化

2020-01-04

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？

2019-04-22

科室
- - 订阅+
  - 更多科室
工具
服务